Explore ViiV Healthcare
Triumeq (dolutegravir/abacavir/lamivudine) is listed on the Pharmaceutical Benefits Scheme (PBS) in Australia as a Section 100 item for the treatment of HIV infection.
Report adverse event
If you are a patient and have experienced an unexpected event when taking one of our medications please speak to your healthcare professional as soon as possible. To lodge a report contact:
Phone: 1800 499 226